Search Results - "Ingelfinger JR"

Melamine and the global implications of food contamination.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 12/25/2008, Vol. 359 Issue 26, p2745-2748. 4p.

Immunosuppression--the promise of specificity.

Authors: Ingelfinger JR Schwartz RS Ingelfinger, Julie R et al.

Source: New England Journal of Medicine. 8/25/2005, Vol. 353 Issue 8, p836-839. 4p.

Case records of the Massachusetts General Hospital. Case 16-2005. A nine-year-old girl with headaches and hypertension.

Authors: Kohane DS Ingelfinger JR Nimkin K et al.

Source: New England Journal of Medicine. 5/26/2005, Vol. 352 Issue 21, p2223-2231. 9p.

Pediatric antecedents of adult cardiovascular disease -- awareness and intervention.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 5/20/2004, Vol. 350 Issue 21, p2123-2126. 4p.

Aliskiren and dual therapy in type 2 diabetes mellitus.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 6/5/2008, Vol. 358 Issue 23, p2503-2505. 3p.

URL: 32502736

Prematurity and the legacy of intrauterine stress.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 5/17/2007, Vol. 356 Issue 20, p2093-2095. 3p.

URL: 25295955

Correction of anemia -- payoffs and problems.

Authors: Remuzzi G Ingelfinger JR

Source: New England Journal of Medicine. 11/16/2006, Vol. 355 Issue 20, p2144-2146. 3p.

Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance -- is there still hope?

Authors: Ingelfinger JR Solomon CG

Source: New England Journal of Medicine. 10/12/2006, Vol. 355 Issue 15, p1608-1610. 3p.

Women in academic medicine -- progress and challenges.

Authors: Hamel MB Ingelfinger JR Phimister E et al.

Source: New England Journal of Medicine. 7/20/2006, Vol. 355 Issue 3, p310-312. 3p.

Risks and benefits to the living donor.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 8/4/2005, Vol. 353 Issue 5, p447-449. 3p.

Agonistic autoantibodies and rejection of renal allografts.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 2/10/2005, Vol. 352 Issue 6, p617-619. 3p.

Grants, politics, and the NIH.

Authors: Drazen JM Ingelfinger JR

Source: New England Journal of Medicine. 12/4/2003, Vol. 349 Issue 23, p2259-2261. 3p.

Diet and kidney stones.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 1/10/2002, Vol. 346 Issue 2, p74-76. 3p.

Registry research and medical privacy.

Authors: Ingelfinger JR Drazen JM

Source: New England Journal of Medicine. 4/1/2004, Vol. 350 Issue 14, p1452-1453. 2p.

Is microanatomy destiny?

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 1/9/2003, Vol. 348 Issue 2, p99-100. 2p.

Ambulatory blood-pressure monitoring as a predictive tool.

Authors: Ingelfinger JR (AUTHOR)

Source: New England Journal of Medicine. 9/12/2002, Vol. 347 Issue 11, p778-779. 2p.

Clinical decisions. Treatment of a 6-year-old girl with vesicoureteral reflux--polling results.

Authors: Lamas DJ Ingelfinger JR Rosenbaum LS

Source: New England Journal of Medicine. 8/25/2011, Vol. 365 Issue 8, pe17-e17. 1p.

Clinical decisions. Management of type 2 diabetes--polling results.

Authors: Halperin F Ingelfinger JR McMahon GT et al.

Source: New England Journal of Medicine. 2/14/2008, Vol. 358 Issue 7, pe8-e8. 1p.

URL: 29418992

Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression.

Authors: Nestoridi E Kushak RI Tsukurov O et al.

Source: Pediatric Nephrology. Feb2008, Vol. 23 Issue 2, p221-231. 11p.

URL: 28352209

Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system.

Authors: Chang SY Chen YW Zhao XP et al.

Source: Diabetes. Oct2012, Vol. 61 Issue 10, p2565-2574. 10p.